SynthesisBMJ open2020

Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability.

Nessa Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.